OXBDF
Price
$4.28
Change
-$0.38 (-8.15%)
Updated
Jun 17 closing price
Capitalization
460.09M
PBIGF
Price
$0.26
Change
+$0.04 (+18.18%)
Updated
May 16 closing price
Capitalization
81.57M
Interact to see
Advertisement

OXBDF vs PBIGF

Header iconOXBDF vs PBIGF Comparison
Open Charts OXBDF vs PBIGFBanner chart's image
Oxford Biomedica
Price$4.28
Change-$0.38 (-8.15%)
Volume$500
Capitalization460.09M
Paradigm Biopharmaceuticals
Price$0.26
Change+$0.04 (+18.18%)
Volume$1.5K
Capitalization81.57M
OXBDF vs PBIGF Comparison Chart in %
Loading...
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OXBDF vs. PBIGF commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OXBDF is a Hold and PBIGF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (OXBDF: $4.28 vs. PBIGF: $0.26)
Brand notoriety: OXBDF and PBIGF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OXBDF: 2% vs. PBIGF: 52%
Market capitalization -- OXBDF: $460.13M vs. PBIGF: $77.55M
OXBDF [@Biotechnology] is valued at $460.13M. PBIGF’s [@Biotechnology] market capitalization is $77.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OXBDF’s FA Score shows that 0 FA rating(s) are green whilePBIGF’s FA Score has 0 green FA rating(s).

  • OXBDF’s FA Score: 0 green, 5 red.
  • PBIGF’s FA Score: 0 green, 5 red.
According to our system of comparison, PBIGF is a better buy in the long-term than OXBDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OXBDF’s TA Score shows that 3 TA indicator(s) are bullish while PBIGF’s TA Score has 3 bullish TA indicator(s).

  • OXBDF’s TA Score: 3 bullish, 3 bearish.
  • PBIGF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, OXBDF is a better buy in the short-term than PBIGF.

Price Growth

OXBDF (@Biotechnology) experienced а 0.00% price change this week, while PBIGF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OXBDF($460M) has a higher market cap than PBIGF($81.6M). PBIGF YTD gains are higher at: -6.207 vs. OXBDF (-20.736).
OXBDFPBIGFOXBDF / PBIGF
Capitalization460M81.6M564%
EBITDAN/A-15.46M-
Gain YTD-20.736-6.207334%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OXBDF vs PBIGF: Fundamental Ratings
OXBDF
PBIGF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
5144
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OXBDF's Valuation (70) in the null industry is in the same range as PBIGF (90). This means that OXBDF’s stock grew similarly to PBIGF’s over the last 12 months.

OXBDF's Profit vs Risk Rating (100) in the null industry is in the same range as PBIGF (100). This means that OXBDF’s stock grew similarly to PBIGF’s over the last 12 months.

OXBDF's SMR Rating (93) in the null industry is in the same range as PBIGF (97). This means that OXBDF’s stock grew similarly to PBIGF’s over the last 12 months.

PBIGF's Price Growth Rating (44) in the null industry is in the same range as OXBDF (51). This means that PBIGF’s stock grew similarly to OXBDF’s over the last 12 months.

OXBDF's P/E Growth Rating (98) in the null industry is in the same range as PBIGF (100). This means that OXBDF’s stock grew similarly to PBIGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OXBDFPBIGF
RSI
ODDS (%)
Bearish Trend 4 days ago
52%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
44%
Momentum
ODDS (%)
Bearish Trend 4 days ago
48%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
33%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
OXBDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGCCX96.900.82
+0.85%
Gabelli Growth C
LAIDX9.500.07
+0.74%
Lord Abbett International Value I
ALPGF0.02N/A
N/A
Alpha Growth PLC
ICPUX6.30-0.01
-0.16%
Integrity Mid-North American Resources C
ASVNX8.70-0.02
-0.23%
American Century Small Cap Value C

OXBDF and

Correlation & Price change

A.I.dvisor tells us that OXBDF and SER have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OXBDF and SER's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OXBDF
1D Price
Change %
OXBDF100%
N/A
SER - OXBDF
25%
Poorly correlated
+0.65%
XTLB - OXBDF
24%
Poorly correlated
N/A
TBPH - OXBDF
24%
Poorly correlated
N/A
ATNM - OXBDF
24%
Poorly correlated
-12.35%
YECO - OXBDF
22%
Poorly correlated
N/A
More

PBIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBIGF has been loosely correlated with ABEO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBIGF jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBIGF
1D Price
Change %
PBIGF100%
N/A
ABEO - PBIGF
34%
Loosely correlated
-2.54%
STTK - PBIGF
21%
Poorly correlated
-8.27%
ARWR - PBIGF
21%
Poorly correlated
+0.06%
OXBDF - PBIGF
7%
Poorly correlated
N/A
PTCHF - PBIGF
6%
Poorly correlated
N/A
More